rawfin.tv
BlackRock Discloses 5.7% Stake in Revolution Medicines
MarketsstocksAI Generated

BlackRock Discloses 5.7% Stake in Revolution Medicines

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

BlackRock, Inc. (BLK) has reported a 5.7% beneficial ownership stake in Revolution Medicines (RVMD). This amounts to 12,201,395 shares of the biotechnology company.

BLKRVMDInstitutional OwnershipBiotechnology

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks